Lumida
/MAPS
⌘K
WM Technology Inc

WM Technology Inc

MAPS
$0.38USD↓-0.52%-0.00 today

MARKET CAP

60.5M

P/E (TTM)

3.2x

FWD P/E

3.1x

DAY RANGE

$0 – $0

52W RANGE

$0
$1

AI Summary

Stalk
Buy NowMedium

MAPS has reached a capitulation low and formed a tight, low‐volume candle cluster indicating exhaustion of selling. Valuation metrics and extreme oversold readings qualify it for mean reversion, and the Post‐Capitulation pattern confirms forced liquidation is mostly complete. Price is now pulling back into the 9/21 EMA area above the absorption zone, offering a structurally sound entry point. Timing conditions are favorable for a tactical mean reversion buy.

  • ↑Q1 2026 cash & investments $57 M with zero debt enables strategic flexibility.
  • ↑Adjusted EBITDA of $10.1 M in Q1 2026 reflects disciplined cost management.
  • ↓Q1 2026 revenue fell 2% YoY to $43.6 M; CFO forecasts low-single-digit Q2 decline.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

WM Technology, Inc. (NASDAQ: MAPS) is a leading technology and marketplace platform dedicated to the cannabis industry, specifically through its WeedMaps service. WM Technology connects consumers with cannabis retailers and brands while navigating a complex and evolving regulatory landscape. The company is currently positioned to benefit from emerging markets, particularly New York, as it responds to ongoing market dynamics amid industry consolidation and elevated competition.

Bull says

  • ↑Q1 2026 cash & investments $57 M with zero debt enables strategic flexibility.
  • ↑Adjusted EBITDA of $10.1 M in Q1 2026 reflects disciplined cost management.
  • ↑New client count grew to 5,241 in key emerging markets (NY, OH).
  • ↑Investing in AI/ML platform enhancements to boost engagement and efficiency.
  • ↑Revamped marketing via brand activations aims to reignite customer growth.
  • ↑Strong quality factor, high leverage capacity, and positive oil sensitivity support upside.

Bear says

  • ↓Q1 2026 revenue fell 2% YoY to $43.6 M; CFO forecasts low-single-digit Q2 decline.
  • ↓Average monthly paying clients at ~4,983, down 4% YoY, highlighting churn issues.
  • ↓Price compression and elevated excise taxes erode operator spending and margins.
  • ↓Negative earnings yield and low profitability factors signal poor returns.
  • ↓Size factor exposure suggests scaling struggles versus peers in mature markets.
  • ↓Illicit-market competition intensifies supply imbalance and further pressures pricing.

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-13-2026neutral

Transcript signals

Bull points

  • This represents an important milestone for the cannabis industry, and a meaningful recognition of the role medical cannabis plays for patients across the country.
  • We view any progress at the federal level as constructive and are encouraged to continue to see continued movement toward a more rational regulatory framework for cannabis in the United States.
  • we were pleased with our first quarter results, which came in in line with our revenue expectations and reflected another quarter of disciplined execution in a constrained environment.

Bear points

  • Revenue for the first quarter was $43.6 million, down 2% year-over-year and up 1% sequentially in line with expectations.
  • These dynamics continue to weigh on client retention during the quarter.
  • Average monthly paying clients were approximately 4,983, down 4% year-over-year and 3% sequentially. The decline was primarily driven by churn in mature markets, where operator financial pressure has contributed to business closures and account removals from the platform related to nonpayment.
Read full transcript analysis ›